We are live on ! Find out more
ABBV icon

AbbVie
ABBV

1,286 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,286 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.14% more ownership

Funds ownership: 0% → 68.14% (+68%)

33% more call options, than puts

Call options by funds: $182M | Put options by funds: $137M

Holders
1,286
Holders Change
+1,286
Holders Change %
–
% of All Funds
41.97%
Holding in Top 10
39
Holding in Top 10 Change
+39
Holding in Top 10 Change %
% of All Funds
1.27%
New
1,286
Increased
–
Reduced
–
Closed
–
Calls
$182M
Puts
$137M
Net Calls
+$45.2M
Net Calls Change
+$45.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LSA
1026
L & S Advisors
California
$481K +$509K +11,637 New
CHAM
1027
Clear Harbor Asset Management
Connecticut
$481K +$509K +11,640 New
LRPA
1028
L. Roy Papp & Associates
Arizona
$480K +$508K +11,613 New
LKIM
1029
Lawson Kroeker Investment Management
Nebraska
$477K +$505K +11,540 New
CCA
1030
Conestoga Capital Advisors
Pennsylvania
$477K +$505K +11,550 New
CAI
1031
Capital Advisors Inc
Oklahoma
$475K +$503K +11,500 New
VCM
1032
Violich Capital Management
California
$472K +$499K +11,409 New
GHAM
1033
Gilman Hill Asset Management
Connecticut
$472K +$500K +11,423 New
MGIA
1034
Moneta Group Investment Advisors
Missouri
$471K +$499K +11,403 New
MBT
1035
Montecito Bank & Trust
California
$470K +$497K +11,363 New
CC
1036
Capital Counsel
New York
$469K +$496K +11,350 New
KLWA
1037
Kelly Lawrence W & Associates
California
$467K +$495K +11,310 New
AW
1038
ACG Wealth
Georgia
$463K +$490K +11,211 New
PCMC
1039
Paragon Capital Management (Colorado)
Colorado
$461K +$488K +11,163 New
AP
1040
Advisor Partners
California
$461K +$487K +11,140 New
TCOO
1041
Trust Company of Oklahoma
Oklahoma
$461K +$487K +11,144 New
TCMG
1042
TSP Capital Management Group
New Jersey
$459K – – –
WKA
1043
Wilson Kemp & Associates
Michigan
$452K +$479K +10,942 New
YIA
1044
YHB Investment Advisors
Connecticut
$443K +$468K +10,711 New
AMG
1045
Asset Management Group
Connecticut
$432K +$457K +10,440 New
MC
1046
Menta Capital
California
$430K +$455K +10,400 New
NAM
1047
Nichols Asset Management
Massachusetts
$430K +$456K +10,420 New
NAM
1048
Needelman Asset Management
California
$429K +$454K +10,372 New
BRWA
1049
B. Riley Wealth Advisors
Florida
$425K +$450K +10,291 New
FANJ
1050
Financial Architects (New Jersey)
New Jersey
$423K +$448K +10,232 New
40 41
42
43 44

ABBV Hedge Fund Activity: Q2 2013 in Review

1,286 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.

Buyers outnumbered sellers: 1,286 funds opened new ABBV positions and 0 closed out — a net gain of 1,286 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,286 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.6B of AbbVie stock for Q2 2013.
  • 1,286 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,286 holders.

Based on aggregated 13F filings for Q2 2013.